COPAXONE® (glatiramer acetate injection) 40 mg/mL Logo
Shared Solutions®
Copaxone® is the #1 prescribed brand for relapsing MS in the US 1*

3-times-a-week COPAXONE® 40 mg/mL has wide formulary coverage

It's important to Teva that COPAXONE® patients find affordable access to therapy. Teva’s Shared Solutions® helps patients find personalized financial solutions to help them start on 3-times-a-week COPAXONE® 40 mg/mL.

Teva's Shared Solutions® offers

Your Patient's COPAXONE® Prescription

Pharmacy Coverage and Logistics

Remind your patients that their voice matters. Tell them to speak to their pharmacist to ensure that they are receiving Teva's COPAXONE® as you prescribed or they might get the generic instead.

Remind your patients they can call Teva's Shared Solutions® for support at any time.

Specify Dispense as Written (DAW) every time you write a COPAXONE® prescription, for new and refill prescriptions, either when using the Prescription & Service Request Form (PSR) or otherwise.

Download the Prescription & Service Request Form (PSR) to get your patient started today.


COPAXONE Co-pay Solutions®

Through COPAXONE Co-pay Solutions®, eligible patients can reduce their co-pay for 3-times-a-week COPAXONE® 40 mg/mL to $0 per month*


*Applies only to 3-times-a-week COPAXONE® 40 mg. Certain limits and restrictions apply. See Terms and Conditions.

Benefits investigation

Teva’s Shared Solutions® has a team of dedicated Case Managers who research and understand your patients' insurance coverage and benefits, so you can be confident that someone is working hard to help make their COPAXONE® therapy affordable.
See the range of services offered by Teva’s Shared Solutions® Case Managers

Have your patients contact Teva's Shared Solutions® at COPAXONE.com for a full benefits investigation for 3-times-a-week COPAXONE® 40 mg/mL, or call 1-800-887-8100.

Teva’s Shared Solutions® offers a full range of support services to help your COPAXONE® patients reach their treatment goals
See All Services
In-home initial injection trainings help support patients' injection experience
Learn more
Teva’s Clinical Nurse Educators (CNEs) offer personalized services and support for you, your patients, and the RMS community
View CNE services

Injections for 3-times-a-week COPAXONE® 40 mg must be at least 48 hours apart.


COPAXONE® is contraindicated in patients with known hypersensitivity to glatiramer acetate or mannitol.
Approximately 16% of patients exposed to COPAXONE® 20 mg per mL compared to 4% of those on placebo, and approximately 2% of

You are now leaving this website

The website you are about to visit does not belong to Teva Neuroscience, Inc. or follow the same terms of service. Some of these websites may also require a third-party account, subscription, or payment to view.

While we carefully choose which websites we link to, we cannot control any changes or actions made by them. As a result, Teva makes no warranties or representations of any kind as to the accuracy, currency, or completeness of the following site, nor any liability on their behalf.

Continue to site